Joel Greenblatt - Gotham Asset Management
Holding/activity history for Krystal Biotech, Inc. (KRYS)
← All KRYS superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 1,323 | <0.01 | Add 1.53% | $235.60–298.30 · VW $265.68i | $341,757 | SEC | |
| 2025 Q4 | 1,303 | <0.01 | Reduce 0.31% | $179.19–265.92 · VW $213.09i | $321,242 | SEC | |
| 2025 Q3 | 1,307 | <0.01 | Buy | <0.01 | $130.50–183.58 · VW $151.98i | $230,725 | SEC |
| 2025 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | $122.80–176.73 · VW $143.23i | SEC | |
| 2025 Q1 | 4,804 | <0.01 | Buy | <0.01 | $141.72–197.94 · VW $169.28i | $866,161 | SEC |
Price snapshot:
Current price$363.44
Avg. buy price$177.77
+/- since buy104.45%
52-week low$130.50
52-week high$382.54